Raj, R.; Kumar, A.; Prachi Sood; Kumar, R.; Rana, V. Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel As First Line Treatment in Women With Advanced Breast Cancer. J. Res. Appl. Sci. Biotechnol. 2023, 2, 55-63.